My Locations
About Me
I am a radiation oncologist, which means I evaluate patients with cancer, determine the appropriate treatments, and design personalized radiation treatments. I value and incorporate the input of all the members of the cancer care team (surgeon, medical oncologist, radiologist, etc.) and take a team-based approach to make treatment recommendations. As a physician-scientist, I work in the laboratory to improve strategies for treating cancer, and I aim to take the solutions I identify in the laboratory back into the clinic to more effectively treat patients. Finally, I am a daughter, sister, wife, and mother who understands the toll that cancer can take on a patient and his or her family. In my treatment recommendations and plans, I aspire to incorporate not only the information about my patients’ medical conditions but also to design treatment approaches and plans that incorporate the values and preferences of patients and their loved ones.
- Assistant Professor of Radiation Oncology, Radiation Oncology 2023
- Member of the Duke Cancer Institute, Duke Cancer Institute 2020
Call for an Appointment
Training and Education
Clinical Focus and Research
I believe the key to improving treatment for cancer patients starts at a very basic level of research. My laboratory research focuses on understanding the genetic, epigenetic, and molecular characteristics of cancer cells that resist typical treatments and finding ways to treat them more effectively. My goal is to apply this information to design personalized treatment strategies to effectively treat both sensitive and resistant tumor cells.
- Medical Scientist Training Program awarded by National Institute of General Medical Sciences 2022 - 2027
- Amodeo, Maria E., Christine E. Eyler, and Sarah E. Johnstone. “Rewiring cancer: 3D genome determinants of cancer hallmarks.” Curr Opin Genet Dev 91 (April 2025): 102307. https://doi.org/10.1016/j.gde.2024.102307.
- McDuff, Susan G. R., Karin M. Hardiman, Peter J. Ulintz, Aparna R. Parikh, Hui Zheng, Daniel W. Kim, Jochen K. Lennerz, et al. “Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer.” JCO Precis Oncol 5 (2021). https://doi.org/10.1200/PO.20.00220.
- Lathia, J. D., M. Hitomi, J. Gallagher, S. P. Gadani, J. Adkins, A. Vasanji, L. Liu, et al. “Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions.” Cell Death Dis 2, no. 9 (September 1, 2011): e200. https://doi.org/10.1038/cddis.2011.80.
- Eyler, Christine Elissa, Michael T. Forrester, Anita B. Hjelmeland, and Jeremy N. Rich. “Heterologous expression of microbial flavohemoglobin can modulate the effects of nitric oxide in mammalian cells.” In FASEB JOURNAL, Vol. 24. FEDERATION AMER SOC EXP BIOL, 2010.
- Eyler, Christine E., Terry L. Jackson, Laura M. De Castro, Rahima Zennadi, Jeffery M. Vance, Allison Ashley-Koch, and Marilyn J. Telen. “Effects of Single Nucleotide Polymorphisms of the β2 Adrenergic Receptor and of Adenylate Cyclase on Sickle Red Cell Adhesion to Laminin.” In Blood, 104:3565–3565. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.3565.3565.
- Murphy, M. M., A. Evans, M. A. Zayed, J. E. Brittain, E. P. Orringer, K. I. Ataga, C. E. Eyler, M. J. Telen, and L. V. Parise. “The small GTPase rapl activates BCAM/LU-dependent but not alpha 4 beta l-dependent adhesion in sickle red blood cells: Evidence for divergent adhesive pathways.” In BLOOD, 102:82A-82A. AMER SOC HEMATOLOGY, 2003.
Insurance Accepted
Please call to see if your insurance is accepted.